ArticleInvestigative ophthalmology & visual science2021

Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma.

Naga Pradeep Rayana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.